Company Profiles

driven by the PitchBook Platform

Embera NeuroTherapeutics

Description

Provider of treatment for smoking cessation, cocaine dependence and other addictions. The company is developing an addiction pharmaceutical (EMB-001) that targets specific and complementary brain functions and drive the craving and relapse associated with these disorders.

2007

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$13.8k

Latest Deal Amount

$17.6M

Total Amount Raised

Description

Provider of treatment for smoking cessation, cocaine dependence and other addictions. The company is developing an addiction pharmaceutical (EMB-001) that targets specific and complementary brain functions and drive the craving and relapse associated with these disorders.

Website:

www.emberaneuro.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

365 Boston Post Road Suite 212 Sudbury, MA 01776United States +1 (978) 579-4156
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Embera NeuroTherapeutics's full profile, request a free trial.

    Embera NeuroTherapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Embera NeuroTherapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Embera NeuroTherapeutics Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BVM CapitalVenture CapitalMinority000 0000000 0000
    HRA PharmaPE-Backed CompanyMinority000 0000000 0000
    Keiretsu CapitalVenture CapitalMinority000 0000000 0000
    Louisiana FundVenture CapitalMinority000 0000000 0000
    National Institute on Drug Abuse (NIDA)Other000 0000000 0000
    BVM Capital Venture Capital
    HRA Pharma PE-Backed Company
    Keiretsu Capital Venture Capital
    Louisiana Fund Venture Capital
    National Institute on Drug Abuse (NIDA) Other

    Embera NeuroTherapeutics Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Robert LinkeChief Executive Officer, Board Member & President
    Nicholas Geoders Ph.DChief Scientific Officer & Director
    Gary ConnorDirector of Clinical Operations
    Carol Gloff Ph.DConsulting Vice President, Pre-Clinical Development and Regulatory Affairs
    Julie Straub Ph.DVice President, CMC and Nonclinical Development
    Robert Linke Chief Executive Officer, Board Member & President
    Nicholas Geoders Ph.D Chief Scientific Officer & Director
    Gary Connor Director of Clinical Operations
    Carol Gloff Ph.D Consulting Vice President, Pre-Clinical Development and Regulatory Affairs
    Julie Straub Ph.D Vice President, CMC and Nonclinical Development

    Embera NeuroTherapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Eirn Gainer Ph.DHRA PharmaBoard Member000 0000
    Franz Hefti Ph.DSelfBoard Member000 0000
    Joseph LovettLouisiana FundBoard Member000 0000
    Robert LinkeEmbera NeuroTherapeuticsChief Executive Officer, Board Member & President000 0000
    Ross Barrett JDBVM CapitalChairman000 0000
    Eirn Gainer Ph.D Board Member HRA Pharma
    Franz Hefti Ph.D Board Member Self
    Joseph Lovett Board Member Louisiana Fund
    Robert Linke Chief Executive Officer, Board Member & President Embera NeuroTherapeutics
    Ross Barrett JD Chairman BVM Capital
    Request full access to PitchBook